Search research articles
Contact Us
Filters
Showing results (31-40 of 43) with videos related to
Page
of 5
Sort By:
Molecular and Cellular Neurosciences
|
April 15, 2003
Suppression of Rho-kinase activity promotes axonal growth on inhibitory CNS substrates
Jaimie F Borisoff, Carmen C M Chan, Gordon W Hiebert, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
September 1, 1993
Characterization of verlukast metabolites arising from an epoxide intermediate produced with hepatic microsomes from beta-naphthoflavone-treated rodents (P-4501A1)
D A Nicoll-Griffith, N Chauret, J A Yergey, et al.
Molecular Pharmacology
|
July 1, 1991
5-Lipoxygenase-activating protein is the target of a quinoline class of leukotriene synthesis inhibitors
J F Evans, C Lévillé, J A Mancini, et al.
Canadian Journal of Physiology and Pharmacology
|
December 1, 1991
Pharmacology of the leukotriene antagonist verlukast: the (R)-enantiomer of MK-571
T R Jones, R Zamboni, M Belley, et al.
Prostaglandins, Leukotrienes, and Medicine
|
January 1, 1984
The development of sensitive and specific radioimmunoassays for leukotrienes
J Rokach, E C Hayes, Y Girard, et al.
Canadian Journal of Physiology and Pharmacology
|
January 1, 1989
Pharmacology of L-660,711 (MK-571): a novel potent and selective leukotriene D4 receptor antagonist
T R Jones, R Zamboni, M Belley, et al.
Biosensors & Bioelectronics
|
July 5, 2019
Engineering of keratin functionality for the realization of bendable all-biopolymeric micro-electrode array as humidity sensor
M Natali, A Campana, T Posati, et al.
The Journal of Biological Chemistry
|
May 16, 2001
The YRD motif is a major determinant of substrate and inhibitor specificity in T-cell protein-tyrosine phosphatase
E Asante-Appiah, K Ball, K Bateman, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 1, 1999
A series of non-quinoline cysLT1 receptor antagonists: SAR study on pyridyl analogs of Singulair
D Guay, J Y Gauthier, C Dufresne, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 18, 1999
Substituted heterocyclic analogs as selective COX-2 inhibitors in the flosulide class
N Ouimet, C C Chan, S Charleson, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 43) with videos related to
Sort By:
Page
of 5
Molecular and Cellular Neurosciences
|
April 15, 2003
Suppression of Rho-kinase activity promotes axonal growth on inhibitory CNS substrates
Jaimie F Borisoff, Carmen C M Chan, Gordon W Hiebert, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
September 1, 1993
Characterization of verlukast metabolites arising from an epoxide intermediate produced with hepatic microsomes from beta-naphthoflavone-treated rodents (P-4501A1)
D A Nicoll-Griffith, N Chauret, J A Yergey, et al.
Molecular Pharmacology
|
July 1, 1991
5-Lipoxygenase-activating protein is the target of a quinoline class of leukotriene synthesis inhibitors
J F Evans, C Lévillé, J A Mancini, et al.
Canadian Journal of Physiology and Pharmacology
|
December 1, 1991
Pharmacology of the leukotriene antagonist verlukast: the (R)-enantiomer of MK-571
T R Jones, R Zamboni, M Belley, et al.
Prostaglandins, Leukotrienes, and Medicine
|
January 1, 1984
The development of sensitive and specific radioimmunoassays for leukotrienes
J Rokach, E C Hayes, Y Girard, et al.
Canadian Journal of Physiology and Pharmacology
|
January 1, 1989
Pharmacology of L-660,711 (MK-571): a novel potent and selective leukotriene D4 receptor antagonist
T R Jones, R Zamboni, M Belley, et al.
Biosensors & Bioelectronics
|
July 5, 2019
Engineering of keratin functionality for the realization of bendable all-biopolymeric micro-electrode array as humidity sensor
M Natali, A Campana, T Posati, et al.
The Journal of Biological Chemistry
|
May 16, 2001
The YRD motif is a major determinant of substrate and inhibitor specificity in T-cell protein-tyrosine phosphatase
E Asante-Appiah, K Ball, K Bateman, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 1, 1999
A series of non-quinoline cysLT1 receptor antagonists: SAR study on pyridyl analogs of Singulair
D Guay, J Y Gauthier, C Dufresne, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 18, 1999
Substituted heterocyclic analogs as selective COX-2 inhibitors in the flosulide class
N Ouimet, C C Chan, S Charleson, et al.
Page
of 5